UNSPSC 85871117: Computerized tomography (ct scan) of sella turcica/pituitary gland using high osmolar contrast, unenhanced and enhanced

This classification denotes the group of activities that yields a imaging intervention or procedure to computerized tomography (ct scan) of sella turcica/pituitary gland using high osmolar contrast, unenhanced and enhancedcomputerized tomography (ct scan) of sella turcica/pituitary gland using high osmolar contrast, unenhanced and enhanced. This intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code B02900Z

UNSPSC 85871117 Computerized tomography (ct scan) of sella turcica/pituitary gland using high osmolar contrast, unenhanced and enhanced is a Commodity code that shows minimal alignment with recent state and local procurement activity. The three most recent opportunities posted under this code—a diagnostic imaging PACS system implementation at San Mateo Medical Center, special education contracted services at Birdville Independent School District, and a temporary health professional staffing pool at Santa Clara Health System—do not reflect purchases of the specific imaging procedure named in the code. San Mateo Medical Center's PACS solicitation addresses enterprise-grade picture archiving and communication system implementation supporting radiology, cardiology, and dental imaging with EPIC integration across approximately 65,000 annual radiology studies, but does not target ct scans of the sella turcica or pituitary gland as a discrete line item. The other two opportunities are entirely unrelated to diagnostic imaging.

The code shows little relevant recent activity in state and local procurement. The geographic spread of recent tagging includes California and Texas, but the opportunities do not represent actual demand for the specific imaging service the code describes. State and local health systems and school districts may purchase this imaging procedure as part of broader diagnostic or clinical service agreements, but the code does not appear to be the primary or consistent procurement vehicle for this work. Business development professionals evaluating this code should confirm actual buying patterns through direct contact with public hospital systems and health authorities rather than rely on recent solicitation tagging.